Imricor Medical Systems (ASX:IMR) ROCE % : -319.18% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Imricor Medical Systems's annualized ROCE % for the quarter that ended in Jun. 2024 was -319.18%.

Imricor Medical Systems ROCE % Historical Data

The historical data trend for Imricor Medical Systems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems ROCE % Chart

Imricor Medical Systems Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-102.52

-58.94

-72.91

-99.91

-295.67

Imricor Medical Systems Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial					-99.95	-113.63	-214.48	-575.96	-319.18

Imricor Medical Systems ROCE % Calculation

Imricor Medical Systems's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-33.732	/	( ( (20.305 - 3.075)	+	(12.412 - 6.825) )	/ 2 )
	=	-33.732	/	( (17.23	+	5.587)	/ 2 )
	=	-33.732	/	11.4085
	=	-295.67 %

Imricor Medical Systems's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-20.63	/	( ( (12.412 - 6.825)	+	(11.605 - 4.265) )	/ 2 )
	=	-20.63	/	( ( 5.587	+	7.34 )	/ 2 )
	=	-20.63	/	6.4635
	=	-319.18 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Imricor Medical Systems (ASX:IMR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Imricor Medical Systems ROCE % Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Gateway Boulevard, Burnsville, MN, USA, 55337

Website

https://www.imricor.com

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems Headlines

No Headlines